Avanir Pharmaceuticals, Inc.
is a biopharmaceutical company focused on acquiring,developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders.

Press Releases

Avanir Pharmaceuticals Reports Fiscal 2012 Second Quarter Financial and Business Results
May 8, 2012
Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
May 1, 2012
Avanir Pharmaceuticals To Present at Three Conferences In May
May 1, 2012
Divider